Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New Podcast CE Alert: "Medications for Opioid Use Disorder" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Psychiatry
  4. Resources
  5. Drugs

Drugs

  • ADHD (81)
  • Agitation (2)
  • Anxiety (29)
  • Bipolar Disorder (17)
  • Depression (278)
  • Mental Health (27)
  • Resources (183)
    • Charts (45)
    • Drugs (55)
      • Anti-Anxiety Drugs (6)
      • Antidepressants (20)
      • Antipsychotics (36)
      • Mood Stabilizers (4)
    • Guidelines (32)
    • Patient Education (8)
    • PL Voices (68)
    • Quality Measures (3)
  • Schizophrenia (64)
  • Sleep Disorders (100)
  • Substance Use Disorder (269)
1 - 15 of 55 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Combining and Augmenting Antidepressants May 2025
Other: Aripiprazole (Abilify Asimtufii LA injectable)
April 2025
Chart: Drugs With Prescribing, Dispensing, or REMS Requirements
September 2024
Article: Know Limitations of the New Antidepressant Gepirone May 2024
Article: Focus on Safety With Long-Acting Injectable Antipsychotics February 2024
Chart: Comparison of Atypical Antipsychotics (Canada) October 2023
Chart: Management of Acute Agitation and Delirium in Adults July 2023
Article: Tailor Initial Treatment of Depression May 2023
Article: Deflate Hype About New Auvelity for Depression December 2022
Algorithm: Drug-Induced QT Prolongation: A Stepwise Approach
August 2022
Article: Individualize the Choice of Antidepressant Combos July 2022
Article: Suggest a Practical Approach to Manage Agitation in Dementia June 2022
Chart: Pharmacotherapy of Dementia Behaviors June 2022
Chart: Meds That Can Increase Blood Pressure April 2022
Article: Stay Alert for Lybalvi, a New Combo Antipsychotic January 2022
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved